FFDKX | GFACX | FFDKX / GFACX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 24 years | - |
Gain YTD | 24.423 | 21.055 | 116% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.25B | 290B | 3% |
Annual Yield % from dividends | 0.63 | 0.00 | - |
Returns for 1 year | 36.85 | 28.04 | 131% |
Returns for 3 years | 28.74 | -3.58 | -803% |
Returns for 5 years | 99.85 | 45.21 | 221% |
Returns for 10 years | 121.96 | 52.57 | 232% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BIPSX | 45.29 | N/A | N/A |
ProFunds Biotechnology UltraSector Svc | |||
VIGIX | 196.10 | -0.56 | -0.28% |
Vanguard Growth Index Institutional | |||
SEEIX | 13.08 | -0.09 | -0.68% |
SEI International Equity I (SIT) | |||
LSRCX | 3.50 | -0.03 | -0.85% |
Lord Abbett Small Cap Value C | |||
MSECX | 14.08 | -0.16 | -1.12% |
Morgan Stanley Inst International Eq C |